Next 10 |
2024-07-17 07:16:11 ET More on Johnson & Johnson Johnson & Johnson Q2 Earnings Preview: Scrutinizing Its Earnings Quality Johnson & Johnson: Remaining A Buy Despite Remaining Risks Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching...
2024-07-16 05:30:00 ET Summary TimesSquare Capital U.S. Small Cap Growth portfolio outperformed the Russell 2000® Growth Index in the second quarter. The portfolio outperformed the Russell Midcap Growth Index in the second quarter. Pulling back by -27% was Legend Biotech,...
2024-07-12 13:59:39 ET More on Legend Biotech Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances Legend Biotech Corporation 2024 Q1 - Results - Earnings Call Presentation Legend Biotech Corporation (LEGN) Q1 2024 Earnings Call Transcript BMO se...
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
2024-07-09 15:00:45 ET More on BioMarin Pharmaceutical, Legend Biotech, etc. Silence Therapeutics: PV Data For Consideration After ASCVD Treatment Results BioMarin: Short-Term Headwinds But Long-Term Opportunities Remain Legend Biotech's Carvykti Faces Stiff Challeng...
2024-07-09 07:06:25 ET Summary 2seventy bio, Inc. focuses on Abecma, an FDA-approved CAR T cell therapy for multiple myeloma. TSVT's strategic realignment includes selling non-core assets to Regeneron and Novo Nordisk. Abecma shows favorable clinical data but faces strong comp...
2024-07-02 08:23:40 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strateg...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-25 07:20:00 ET Summary TimesSquare Capital Management, LLC is a fundamental research-oriented growth equity investment management firm specializing in growth equity strategies for institutional investors. TimesSquare uses a well-established team approach to growth investing th...
2024-06-21 09:35:00 ET Summary TimesSquare Capital Management, LLC is a fundamental research-oriented growth equity investment management firm specializing in growth equity strategies for institutional investors. TimesSquare uses a well-established team approach to growth investing th...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...